<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related mortality in the western world </plain></SENT>
<SENT sid="1" pm="."><plain>It is also the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosed in both men and women in the United States with a recent estimate for new cases of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in the year 2012 being around 103,170 </plain></SENT>
<SENT sid="2" pm="."><plain>Various risk factors for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> include life-style, diet, age, personal and family history, and racial and ethnic background </plain></SENT>
<SENT sid="3" pm="."><plain>While a few <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are certainly preventable but this does not hold true for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> as it is often detected in its advanced stage and generally not diagnosed until symptoms become apparent </plain></SENT>
<SENT sid="4" pm="."><plain>Despite the fact that several options are available for treating this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> through surgery, chemotherapy, radiation therapy, immunotherapy, and <z:chebi fb="10" ids="50733">nutritional-supplement</z:chebi> therapy, but the success rates are not very encouraging when used alone where secondary complications appear in almost <z:hpo ids='HP_0000001'>all</z:hpo> these therapies </plain></SENT>
<SENT sid="5" pm="."><plain>To maximize the therapeutic-effects in patients, combinatorial approaches are essential </plain></SENT>
<SENT sid="6" pm="."><plain>In this review we have discussed the therapies previously and currently available to patients diagnosed with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal-cancer</z:e>, focus on some recent developments in basic research that has shaded lights on new therapeutic-concepts utilizing macrophages/dendritic cells, natural killer cells, gene delivery, siRNA-, and microRNA-technology, and specific-targeting of tyrosine kinases that are either mutated or over-expressed in the cancerous cell to treat these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Potential strategies are discussed where these concepts could be applied to the existing therapies under a comprehensive approach to enhance the therapeutic effects </plain></SENT>
</text></document>